26 C
Mumbai
Friday, December 2, 2022

Covovax: Serum’s Covid-19 vaccine available to all above age 12

- Advertisement -

Serum Institute of India chief Adar Poonawalla says Covid-19-vaccine Covovax is now available to anybody above the age of 12. This comes only a day after the SII chairman said that youngsters aged 12 to 17 in India can now receive Covovax.

Adar Poonawalla, CEO of the Pune-based Serum Institute of India, stated on Wednesday that the COVID-19 vaccination Covovax is available to anybody above the age of 12. This comes only a day after the SII chairman said that youngsters aged 12 to 17 in India can now receive Covovax.

On Wednesday, Poonawalla tweeted that many people have inquired as to whether Covovax is accessible for adults. He confirmed that Covovax can be availed by everyone above the age of 12 years old.

Covovax (Novavax), which is now accessible in India for youngsters, this is the only vaccination produced in India that is also available in Europe and has a 90% effectiveness rate.  This is consistent with Prime Minister Narendra Modi’s objective of delivering another another vaccination to protect our children, as he stated in a tweet.

The National Technical Advisory Group on Immunisation (NTAGI) last week authorized the Serum Institute of India’s Covovax COVID-19 vaccine for children aged 12 to 17. The government licensed Covovax for restricted use in an emergency situation in December of last year.

Meanwhile, a large number of Twitter users complained that the Covovax option is not available on the CoWIN app for vaccine recipients above the age of 18. “If the 18 and above tab is selected, the Cowin does not provide Covovax. We hope, that issue will be looked into,” remarked one person.

Another person submitted an image of the CoWIN app and stated, “Check this out, when we pick 18 & above option in CoWIN app, immediately Covovax option gets faded i.e disabled while four other alternatives are highlighted i.e Covishield, Covaxin, Sputnik, ZyCov-D.”

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -spot_img

Latest Articles